Literature DB >> 318824

Clindamycin and gentamicin for aerobic and anaerobic sepsis.

R J Fass, D E Ruiz, W G Gardner, C A Rotilie.   

Abstract

Thirty-eight adult patients with serious pleuropulmonary, soft-tissue, bone, and intra-abdominal infections caused by combinations of aerobic, facultative, and anaerobic bacteria were treated with parenterally given clindamycin phosphate and gentamicin sulfate and surgery when appropriate. Nine had associated bacteremia. In 29, infections failed to respond to other therapeutic regimens, which included penicillins, cephalosporins, aminoglycosides, and chloramphenicol. Results with clindamycin and gentamicin were excellent and were attributed primarily to the activity of clindamycin against anaerobes, particularly Bacteroides fragilis. Serum concentrations of clindamycin surpassed by manyfold the minimal inhibitory concentrations (MICs) for anaerobes. Serum concentrations of gentamicin did not consistently surpass the MICs for Enterobacteriaceae and Pseudomonas aeruginosa, although those organisms were consistently gentamicinsusceptible by disk diffusion susceptibility tests. Persistent colonization with Enterobacteriaceae, P aeruginosa, enterococci, or Candida were common, and occasionally they were significant in prolonging the clinical courses of patients with extensive infections.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 318824

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Current antibiotic usage II: Aminoglycosides, tetracyclines, erythromycin, vancomycin and sulphonamides.

Authors:  S M Merchant; N P Vithlani
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

Review 2.  Antibiotic trials in intra-abdominal infections. A critical evaluation of study design and outcome reporting.

Authors:  J S Solomkin; J L Meakins; M D Allo; E P Dellinger; R L Simmons
Journal:  Ann Surg       Date:  1984-07       Impact factor: 12.969

3.  Results of a clinical trial of cefoxitin, a new cephamycin antibiotic.

Authors:  R V McCloskey
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

4.  Use of an immunoperoxidase method for identification of Bacteroides fragilis.

Authors:  P C Hsu; B H Minshew; B L Williams; E S Lennard
Journal:  J Clin Microbiol       Date:  1979-09       Impact factor: 5.948

5.  Susceptibility of Clostridium botulinum to thirteen antimicrobial agents.

Authors:  J M Swenson; C Thornsberry; L M McCroskey; C L Hatheway; V R Dowell
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.